# Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants

> **NCT02720328** · PHASE4 · COMPLETED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 102 (actual)

## Conditions studied

- Embolism and Thrombosis
- Hemorrhage

## Interventions

- **BIOLOGICAL:** Blood samples for DOAC measurement

## Key facts

- **NCT ID:** NCT02720328
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-01
- **Final completion:** —
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2016-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02720328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02720328, "Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02720328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*